Barroso-Aguirre J, Ugarte RF, Pimentel-Nieto D

Language: Spanish
References: 11
Page: 254-261
PDF size: 147.30 Kb.

ABSTRACT

Objective: To determine the prevalence of erectile dysfunction in urban population from Mexico, in males between the 18 and the 40 years old.
Material and methods: This is an epidemiological, transversal and analytic study, it was carried out through a structured survey in homes applied 18 year-old and more, carried out by professional, and previously trained and standardized personal. The work was coordinated by the Chapter of Erectile Dysfunction of the Mexican Society of Urology and for the Unit of Medical Investigation of the investigation company Gallup Mexico. A randomized sample was selected in urban population of three cities (Mexico City, Guadalajara and Monterrey), taking like base the social and demographic data of the National Census, with an interviewed total of 1,513 subjects.
Results: The total prevalence of erectile dysfunction for this age group was of 9.7%: 7.9% corresponded to low erectile dysfunction, moderate 1.2% and severe 0.6%. In connection with the perception that the interviewees had about their ejaculation, it was found that 80.2% referred it as normal, 12.8% as precocious and 7.0% as slowed. Of the social and demographic variables, of comorbidity and life stylus factors, the basic education only showed a dependence, at the expense of people with primary education, in the categories of light and severe erectile dysfunction. The subjective answers about their capacity to have an erection and to experience orgasm, as well as on the evaluation of their emotional state, were variable that allowed to make a correct prediction.
Conclusions: The erectile dysfunction is product of a wide variety of conditions and it turned out to be a good symptomatic indicator of other aspects of the individual’s life. The prevalence of this problem in this age group was important.

REFERENCES

1. Ugarte-y-Romano F, Barroso-Aguirre J. Prevalencia de disfunción eréctil en México y factores de riesgo asociados. Rev Mex Urol 2001; 61: 63-76

2. Morley JE. Impotence in older men. Hosp Practice 1988; 23: 139-42.

3. Laumann EO, Paik AMA, Raymond C. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999; 281: 537-44.

4. Morillo L. V Reunión de la Sociedad Latinoamericana para el estudio de la impotencia (SLAI) Oct. 1999.

5. NIH Consensus Development Panel on Impotence. Impotence. JAMA 1993; 270: 83-90.

6. Parazzini F, Menchini FF, Bortolotti, AC, Chatenoud EC. Frequency and determinants of erectile dysfunction in Italy. Europ Urology 2000; 37: 43-9.

7. Ventegodt S. Sex and the quality of life in Denmark. Arch Sex Behav 1998; 27: 295-307.

8. Virag R. Intracavernous injection of papaverine for erectile failure. Lancet 1982; 2: 938.

9. Rosen RC, Riley A, Wagner G: International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30.

10. Méndez-Castellano H, de Mendez MC. Validaciones estadísticas del método Graffar- Méndez Castellano (VII). En: Sociedad y Estratificación. Editado y publicado por Fundacredesa. Caracas, Venezuela. 1994.

11. Martín-Morales A, Sánchez-Cruz JJ, Sáenz de Tejada I, Rodríguez-Vela L, Jimenez-Cruz JF, Burgos-Rodríguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the epidemiología de la Disfunción Eréctil Masculina study. J Urol 2001;166: 569-75.